David N. Gill, Director at Y-mAbs Therapeutics, Inc. (YMAB), sold 4,000 shares at $45.00 ($180K) on 2020-11-03, disclosed to the SEC on 2020-11-05.
Open-market sale of $180k YMAB by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| YMAB | SELL | 2021-01-20 | $93K | — | Filing → |
| YMAB | SELL | 2020-11-20 | $92K | — | Filing → |
| SBBP | BUY | 2020-09-28 | $17K | — | Filing → |